Amgen Inc

Stock Chart, Company Information, and Scan Results

$384.50(as of Feb 6, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Amgen Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$384.50
Ticker SymbolAMGN
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees28,000
CountyUSA
Market Cap$198,244.2M
EBIDTA17,064.0M
10-Day Moving Average352.96
P/E Ratio27.06
20-Day Moving Average343.07
Forward P/E Ratio16.75
50-Day Moving Average335.30
Earnings per Share14.23
200-Day Moving Average300.26
Profit Margin13.51%
RSI75.55
Shares Outstanding539.0M
ATR10.21
52-Week High385.12
Volume3,839,443
52-Week Low255.23
Most Recent Support Level338.59
Book Value8,658.0M
Most Recent Resistance Level353.25
P/B Ratio24.10
Upper Keltner366.05
P/S Ratio5.68
Lower Keltner320.09
Debt-to-Equity Ratio366.05
Next Earnings Date04/29/2026
Cash Surplus-16,360.0M
Next Ex-Dividend Date02/13/2026

Amgen is a leader in medicinal breakthroughs as it pioneered ways to use living cells to develop biological medicines. The biotech develops and commercializes drugs to treat conditions like cancer, cardiovascular disease, and bone health. The company’s top-selling drugs, Aranesp and Kyprolis, are used to treat anemia and cancer respectively.

Amgen Inc In Our Stock Scanner

As of Feb 06, 2026
As of ---
example chart graphic
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.